As we found that Prmt5 deficiency in fibroblasts suppressed cardiac dysfunction, we hypothesized that PRMT5 inhibitors have anti-heart failure effects via their inhibition of cardiac fibrosis. The gene discussed is PRMT5; the disease is heart failure.